Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Base de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Sci Adv ; 10(32): eadp1657, 2024 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-39121225

RESUMEN

Japanese encephalitis virus (JEV) is a major threat to human health. Bangladesh is considering introducing a JEV vaccine; however, the investment case is hampered by a limited understanding of key aspects of JEV ecology. We conducted a seroprevalence study in a high-incidence region using an assay that limits cross-reactivity with dengue virus. We also trapped mosquitoes and collected information about potential host species. We used mathematical models to recover risk factors for infection and underlying probabilities of severe disease and death. We observed 19.0% [95% confidence interval (CI):17.1 to 21.1] of JEV antibodies. On average, 0.7% (95% CI: 0.2 to 2.0) of the susceptible population gets infected yearly, with pig proximity being the main human infection risk factor. Our traps captured 10 different mosquito species that have been linked with JEV transmission. We estimated that 1 in 1000 infections results in severe disease, 1 in 10,000 results in death, and 76% of severe cases are missed by surveillance.


Asunto(s)
Virus de la Encefalitis Japonesa (Especie) , Encefalitis Japonesa , Vacunas contra la Encefalitis Japonesa , Bangladesh/epidemiología , Humanos , Encefalitis Japonesa/epidemiología , Encefalitis Japonesa/prevención & control , Encefalitis Japonesa/transmisión , Vacunas contra la Encefalitis Japonesa/inmunología , Virus de la Encefalitis Japonesa (Especie)/inmunología , Animales , Estudios Seroepidemiológicos , Adolescente , Adulto , Anticuerpos Antivirales/inmunología , Anticuerpos Antivirales/sangre , Niño , Masculino , Femenino , Adulto Joven , Preescolar , Persona de Mediana Edad , Culicidae/virología , Mosquitos Vectores/virología
2.
J Infect Dis ; 2024 Jun 29.
Artículo en Inglés | MEDLINE | ID: mdl-38942731

RESUMEN

There is an increasing global burden from chikungunya virus (CHIKV). Bangladesh reported a major epidemic in 2017, however, it was unclear if there had been prior widespread transmission. We conducted a nationally representative seroprevalence survey in 70 randomly selected communities immediately prior to the epidemic. We found 69/2,938 (2.4%) of sampled individuals were seropositive to CHIKV. Being seropositive to dengue virus (aOR 3.13 [95% CIs: 1.86-5.27]), male sex (aOR 0.59 [95% CIs: 0.36-0.99]), and community presence of Aedes aegypti mosquitoes (aOR: 1.80, 95% CI: 1.05-3.07) were significantly associated with CHIKV seropositivity. Using a spatial prediction model, we estimated that across the country, 4.99 (95% CI: 4.89 - 5.08) million people had been previously infected. These findings highlight high population susceptibility prior to the major outbreak and that previous outbreaks must have been spatially isolated.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA